TMIC-35. IDH1 MUTATION IN GLIOMA REPROGRAMS EARLY MYELOID DIFFERENTIATION IN THE BONE MARROW (BM) TO PRODUCE NON-IMUNESUPPRESSIVE NEUTROPHILS

Gliomas are the most common primary brain tumors; patients exhibit a poor prognosis. Mutations in isocitrate dehydrogenase (mIDH) are present in most patients with lower grade glioma (LGG), and are correlated with better prognosis and survival. We postulated that mIDH1 induces epigenetic reprogrammi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Alghamri, Mahmoud, Castro, Maria, Lowenstein, Pedro, Kamran, Neha, Kadiyala, Padma, Avvari, Ruthvik, Zhang, Li
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2019
Assuntos:
Tumor Microenvironment
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6846775/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.1069
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares